Central Pacific Bank Trust Division Buys Shares of 3,094 Synopsys, Inc. $SNPS

Central Pacific Bank Trust Division bought a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the second quarter, Holdings Channel.com reports. The institutional investor bought 3,094 shares of the semiconductor company’s stock, valued at approximately $1,586,000.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after acquiring an additional 346,994 shares during the last quarter. Pictet Asset Management Holding SA lifted its stake in shares of Synopsys by 38.3% in the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after buying an additional 673,837 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Synopsys by 6.6% in the first quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock worth $863,500,000 after buying an additional 125,199 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Synopsys by 20.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock worth $778,928,000 after buying an additional 305,489 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its stake in shares of Synopsys by 22.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after buying an additional 313,218 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on SNPS shares. Robert W. Baird restated a “neutral” rating and issued a $535.00 price objective (down from $670.00) on shares of Synopsys in a research note on Wednesday. Wall Street Zen cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday. Morgan Stanley reduced their price objective on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research note on Thursday. The Goldman Sachs Group reduced their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Needham & Company LLC reduced their price objective on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday. Eleven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $585.33.

Check Out Our Latest Report on Synopsys

Synopsys Trading Down 2.9%

Shares of SNPS stock opened at $425.45 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The firm’s fifty day simple moving average is $590.39 and its 200 day simple moving average is $506.54. The firm has a market capitalization of $79.03 billion, a P/E ratio of 33.39, a price-to-earnings-growth ratio of 3.32 and a beta of 1.14. The company has a current ratio of 1.62, a quick ratio of 6.85 and a debt-to-equity ratio of 0.52.

Insider Buying and Selling

In related news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the transaction, the chief financial officer owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This trade represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 24,031 shares of company stock valued at $13,168,999. 0.62% of the stock is owned by company insiders.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.